BioLineRx Ltd. To Report Fourth Quarter And Year End 2013 Results On March 17, 2014
3/11/2014 6:47:22 AM
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it will release its financial results for the quarter and year ended December 31, 2013 on Monday, March 17, 2014, before the U.S. markets open.
Help employers find you! Check out all the jobs and post your resume.
comments powered by